You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/70945
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCunha, Paulo R.-
dc.contributor.authorBarraviera, Silvia Regina Catharino Sartori-
dc.date.accessioned2014-05-27T11:23:52Z-
dc.date.accessioned2016-10-25T18:26:53Z-
dc.date.available2014-05-27T11:23:52Z-
dc.date.available2016-10-25T18:26:53Z-
dc.date.issued2009-03-01-
dc.identifierhttp://dx.doi.org/10.1590/S0365-05962009000200003-
dc.identifier.citationAnais Brasileiros de Dermatologia, v. 84, n. 2, p. 111-122, 2009.-
dc.identifier.issn0365-0596-
dc.identifier.issn1806-4841-
dc.identifier.urihttp://hdl.handle.net/11449/70945-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/70945-
dc.description.abstractAutoimmune bullous dermatoses are diseases in which blisters and vesicles are the primary and fundamental types of skin lesion. Their classification is based on the location of the blister: intraepidermal and subepidermal. Patients produce autoantibodies against self-specific structures of the skin detectable by immunofluorescence techniques, immunoblotting and ELISA. Recent advances in molecular and cellular biology have brought to knowledge these self-antigens, against which patients are sensitized, and which are found in epidermis or in the dermo-epidermal junction. These are low incidence, but high morbidity diseases that may be fatal. The aim of this article is to review and describe the progress of four autoimmune vesiculobullous disorders: endemic pemphigus foliaceous (wild fire), pemphigus vulgaris, bullous pemphigoid and dermatitis herpetiformis. ©2009 by Anais Brasileiros de Dermatologia.en
dc.format.extent111-122-
dc.language.isopor-
dc.sourceScopus-
dc.subjectAllergy and immunology-
dc.subjectBullous pemphigoid-
dc.subjectDermatitis herpetiformis-
dc.subjectPemphigus-
dc.subjectSkin diseases vesiculobullous-
dc.subjectantibiotic agent-
dc.subjectantigen-
dc.subjectantiparasitic agent-
dc.subjectautoantibody-
dc.subjectazathioprine-
dc.subjectchloroquine-
dc.subjectcyclophosphamide-
dc.subjectcyclosporin-
dc.subjectdapsone-
dc.subjectimmunoglobulin-
dc.subjectmethotrexate-
dc.subjectmethylprednisolone-
dc.subjectmycophenolic acid 2 morpholinoethyl ester-
dc.subjectnicotinamide-
dc.subjectprednisone-
dc.subjectriboflavin-
dc.subjectrituximab-
dc.subjectsulfone-
dc.subjecttetracycline-
dc.subjectbacterial infection-
dc.subjectblister-
dc.subjectbullous pemphigoid-
dc.subjectchill-
dc.subjectclinical classification-
dc.subjectclinical feature-
dc.subjectdermatitis herpetiformis-
dc.subjectdiet therapy-
dc.subjectdrug dose reduction-
dc.subjectendemic disease-
dc.subjectenzyme linked immunosorbent assay-
dc.subjectepidermis-
dc.subjectfever-
dc.subjectgluten free diet-
dc.subjectheadache-
dc.subjecthistopathology-
dc.subjecthuman-
dc.subjecthypotension-
dc.subjectimmunoblotting-
dc.subjectimmunofluorescence-
dc.subjectincidence-
dc.subjectknowledge-
dc.subjectmorbidity-
dc.subjectnausea-
dc.subjectpathogenesis-
dc.subjectpemphigus foliaceus-
dc.subjectpemphigus vulgaris-
dc.subjectplasmapheresis-
dc.subjectpruritus-
dc.subjectreview-
dc.subjectskin defect-
dc.subjectskin sensitization-
dc.subjectstrongyle infection-
dc.subjecttreatment duration-
dc.subjecttreatment response-
dc.subjecturticaria-
dc.subjectAutoantibodies-
dc.subjectAutoantigens-
dc.subjectAutoimmune Diseases-
dc.subjectDermatitis Herpetiformis-
dc.subjectEnzyme-Linked Immunosorbent Assay-
dc.subjectFluorescent Antibody Technique-
dc.subjectHumans-
dc.subjectImmunoblotting-
dc.subjectPemphigoid, Bullous-
dc.subjectSkin Diseases, Vesiculobullous-
dc.titleDermatoses bolhosas auto-imunespt
dc.title.alternativeAutoimmune bullous dermatosesen
dc.typeoutro-
dc.contributor.institutionFaculdade de Medicina de Jundiaí (FMJ)-
dc.contributor.institutionUniversidade de São Paulo (USP)-
dc.contributor.institutionNew York University-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationFaculdade de Medicina de Jundiaí (FMJ)-
dc.description.affiliationUniversidade de São Paulo-
dc.description.affiliationFaculdade de Medicina Universidade de São Paulo, São Paulo (SP)-
dc.description.affiliationNew York University, New York, NY-
dc.description.affiliationDepartamento de Dermatologia e Radioterapia Faculdade de Medicina de Botucatu (FMB), São Paulo (SP)-
dc.description.affiliation, Rua: Isaí Leiner, 152 - Jardim Brasil, 13201 854 Jundiaí SP-
dc.description.affiliationUnespDepartamento de Dermatologia e Radioterapia Faculdade de Medicina de Botucatu (FMB), São Paulo (SP)-
dc.identifier.doi10.1590/S0365-05962009000200003-
dc.identifier.scieloS0365-05962009000200003-
dc.rights.accessRightsAcesso aberto-
dc.identifier.file2-s2.0-67449127608.pdf-
dc.relation.ispartofAnais Brasileiros de Dermatologia-
dc.identifier.scopus2-s2.0-67449127608-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
Show simple item record Show full item record   View Statistics
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.